• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导致COVID-19感染、凝血功能障碍和细胞因子风暴的恶性循环:预防性氧疗能否预防?

"" Leads to Vicious Cycle of Infection, Coagulopathy and Cytokine Storm in COVID-19: Can Prophylactic Oxygen Therapy Prevent It?

作者信息

Chauhan Anshika, Kaur Rajandeep, Chakrbarti Prantar, Pal Arnab

机构信息

Department of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Vivekananda Institute of Medical Sciences, Kolkata, India.

出版信息

Indian J Clin Biochem. 2021 Oct;36(4):468-472. doi: 10.1007/s12291-021-00967-0. Epub 2021 Mar 15.

DOI:10.1007/s12291-021-00967-0
PMID:33746377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7958103/
Abstract

Humankind is facing its worst pandemic of the twenty-first century, due to infection of a novel coronavirus named as SARS-CoV2, started from Wuhan in China. Till now, 15 million people are infected, causing more than 600,000 deaths. The disease, commonly known as, COVID-19, was initially thought to be associated with ARDS only, but later on revealed to have many unexplained and atypical clinical features like coagulopathy and cytokinemia, leading to multi-organ involvements. The patients also suffer from '', where there is no immediate respiratory signs and symptoms even though alarmingly low SpO level. We hypothesize that this covert hypoxemia may lead to molecular changes exacerbating coagulopathy and cytokine storm in COVID19 patients, which again, in turn, causes a vicious cycle of more hypoxemia/hypoxia and progression of the infection to more severe stages through HIF-1α dependent pathway. Although molecular mechanisms are yet to be substantiated by scientific evidence, hypoxemia remains an independent worsening factor in serious COVID 19 patients. Keeping all in mind, we propose that even in the early and asymptomatic cases, prophylactic oxygen therapy to be initiated to break the vicious cycle and to reduce the mortality in COVID 19 to save precious human lives.

摘要

人类正面临着21世纪最严重的大流行,这是由一种名为SARS-CoV2的新型冠状病毒感染引起的,该病毒起源于中国武汉。截至目前,已有1500万人感染,导致60多万人死亡。这种疾病通常被称为COVID-19,最初被认为仅与急性呼吸窘迫综合征(ARDS)有关,但后来发现它有许多无法解释的非典型临床特征,如凝血病和细胞因子血症,导致多器官受累。患者还会出现“隐性低氧血症”,即使血氧饱和度(SpO)水平低得惊人,也没有立即出现的呼吸体征和症状。我们假设,这种隐性低氧血症可能会导致分子变化,加剧COVID-19患者的凝血病和细胞因子风暴,而这反过来又会通过缺氧诱导因子-1α(HIF-1α)依赖途径导致更多低氧血症/缺氧的恶性循环以及感染进展到更严重的阶段。尽管分子机制尚未得到科学证据的证实,但低氧血症仍然是重症COVID-19患者病情恶化的一个独立因素。考虑到所有这些因素,我们建议,即使在早期和无症状病例中,也应开始预防性氧疗,以打破恶性循环,降低COVID-19的死亡率,拯救宝贵的生命。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/8455755/23e423708a0c/12291_2021_967_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/8455755/23e423708a0c/12291_2021_967_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d6a/8455755/23e423708a0c/12291_2021_967_Fig1_HTML.jpg

相似文献

1
"" Leads to Vicious Cycle of Infection, Coagulopathy and Cytokine Storm in COVID-19: Can Prophylactic Oxygen Therapy Prevent It?导致COVID-19感染、凝血功能障碍和细胞因子风暴的恶性循环:预防性氧疗能否预防?
Indian J Clin Biochem. 2021 Oct;36(4):468-472. doi: 10.1007/s12291-021-00967-0. Epub 2021 Mar 15.
2
Correction to: " Leads to Vicious Cycle of Infection, Coagulopathy and Cytokine Storm in COVID-19: Can Prophylactic Oxygen Therapy Prevent It?对《COVID-19中感染、凝血障碍和细胞因子风暴的恶性循环:预防性氧疗能否预防?》的勘误
Indian J Clin Biochem. 2021 Oct;36(4):500. doi: 10.1007/s12291-021-00979-w. Epub 2021 Apr 29.
3
Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications.新型冠状病毒肺炎中的低氧血症与细胞因子风暴:临床意义。
MEDICC Rev. 2021 Jul-Oct;23(3-4):54-59. doi: 10.37757/MR2021.V23.N3.10. Epub 2021 Aug 22.
4
Silent Hypoxemia in Patients with COVID-19 Pneumonia: A Review.新型冠状病毒肺炎患者的静默性低氧血症:综述。
Med Sci Monit. 2021 Oct 12;27:e930776. doi: 10.12659/MSM.930776.
5
Causes of Hypoxemia in COVID-19.新型冠状病毒肺炎(COVID-19)低氧血症的病因
J Evol Biochem Physiol. 2022;58(1):73-80. doi: 10.1134/S0022093022010070. Epub 2022 Mar 5.
6
Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients.凝血功能障碍作为新冠病毒感染患者细胞因子风暴的前驱症状
Front Med (Lausanne). 2020 Oct 23;7:572989. doi: 10.3389/fmed.2020.572989. eCollection 2020.
7
COVID-19 infection and its deadly cytokine storm in a young obese adult.一名年轻肥胖成年人的新冠病毒感染及其致命的细胞因子风暴。
J Community Hosp Intern Med Perspect. 2020 Jul 3;10(4):295-298. doi: 10.1080/20009666.2020.1781030.
8
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
9
Pathogenesis, Diagnosis, and Treatment of Hemostatic Disorders in COVID-19 Patients.COVID-19患者止血障碍的发病机制、诊断与治疗
Acta Naturae. 2021 Apr-Jun;13(2):79-84. doi: 10.32607/actanaturae.11182.
10
Pneumolysis and "Silent Hypoxemia" in COVID-19.新型冠状病毒肺炎中的肺松解术与“沉默性低氧血症”
Indian J Clin Biochem. 2021 Jan;36(1):112-116. doi: 10.1007/s12291-020-00935-0. Epub 2020 Nov 9.

引用本文的文献

1
The roles of macrophages and monocytes in COVID-19 Severe Respiratory Syndrome.巨噬细胞和单核细胞在新型冠状病毒肺炎严重呼吸综合征中的作用。
Cell Insight. 2025 May 8;4(4):100250. doi: 10.1016/j.cellin.2025.100250. eCollection 2025 Aug.
2
Metabolic Reprogramming in SARS-CoV-2 Infection Impacts the Outcome of COVID-19 Patients.SARS-CoV-2 感染中的代谢重编程影响 COVID-19 患者的结局。
Front Immunol. 2022 Jul 11;13:936106. doi: 10.3389/fimmu.2022.936106. eCollection 2022.
3
High mortality among hospitalized adult patients with COVID-19 pneumonia in Peru: A single centre retrospective cohort study.
秘鲁住院成人 COVID-19 肺炎患者死亡率高:一项单中心回顾性队列研究。
PLoS One. 2022 Mar 8;17(3):e0265089. doi: 10.1371/journal.pone.0265089. eCollection 2022.
4
Influence of cuff pressures of automatic sphygmomanometers on pulse oximetry measurements.自动血压计袖带压力对脉搏血氧饱和度测量的影响。
Measurement (Lond). 2022 Jan;187:110329. doi: 10.1016/j.measurement.2021.110329. Epub 2021 Oct 16.
5
Different Outcomes of "Silent Hypoxia" in Patients with COVID-19 Pneumonia: A Case Series and Literature Review.新型冠状病毒肺炎患者“沉默性低氧血症”的不同结局:病例系列及文献综述
Case Rep Crit Care. 2021 Sep 3;2021:1215274. doi: 10.1155/2021/1215274. eCollection 2021.
6
Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes).从病理系统总体论(一般病理过程)角度看 COVID-19 的发病机制和病因治疗问题。
Int J Mol Sci. 2021 Jul 15;22(14):7582. doi: 10.3390/ijms22147582.
7
Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19.抗氧化剂在新冠病毒病神经治疗管理中的应用
Antioxidants (Basel). 2021 Jun 17;10(6):971. doi: 10.3390/antiox10060971.
8
Hypoxia-dependent signaling in perioperative and critical care medicine.围手术期及重症医学中的缺氧依赖性信号传导
J Anesth. 2021 Oct;35(5):741-756. doi: 10.1007/s00540-021-02940-w. Epub 2021 May 18.